Preterm infants who are treated with glucocorticoids could be at a growing risk for damage to the cerebellum in the brain, according to a recent study by scientists from the University of California.

Glucocorticoids are usually administered to premature infants to facilitate lung maturation and normalization of breathing and blood pressure.

The study, ‘Preterm Cerebellar Growth Impairment After Postnatal Exposure to Glucocorticoids’, is published in the journal Science Translational Medicine.